Oaktree Acquisition Corp. III Life Sciences
OACCW | NASDAQ
$0.88
+$0.01 (+1.15%)
May 20, 2026, 11:02 AM ET · Market open
Company Profile
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
Key Executives
| Name | Position |
|---|---|
| Zaid Pardesi | Chief Executive Officer & Director |
| George A. Martinez | Chief Financial Officer, Principal Accounting & Principal Financial Officer |
| Mathew Pendo | Chief Operation Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 26, 2026 | 10-K | Annual Report |
| Feb 11, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 13, 2025 | 10-Q | Quarterly Report |
| Oct 29, 2025 | 3 | Filing |
| Oct 29, 2025 | 8-K | Current Report |
| Oct 22, 2025 | 3 | Filing |
| Oct 17, 2025 | 8-K | Current Report |
| Aug 12, 2025 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 12, 2025 | 10-Q | Quarterly Report |
| Jul 15, 2025 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Oaktree Acquisition Corp. III Life Sciences
| Country | United States |
| IPO Date | Oct 5, 2025 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Mathew Pendo |
Contact Details
333 South Grand Avenue Los Angeles,
California 90071 United States
Stock Details
| Ticker Symbol | OACCW |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0002029769 |
| CUSIP Number | n/a |
| ISIN Number | KYG6717R1121 |
| SIC Code | 6770 |
Add to Watchlist
Select watchlists to add or remove OACCW